ATLAS Market profile
Menu
Atlas · Symbols · ETFs · LGHT

Atlas market file · Etf · United States

Langar Global HealthTech ETFLGHT

Last close
8.164
Change
-0.75%
96-bar range
7.938 – 9.415
As of
23 Jul 2026

Langar Global HealthTech ETF is an exchange-traded fund listed as LGHT on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot BATS:LGHT

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

9.45939.06798.67658.28517.893706 Mar14 May23 Jul

up candle   down candle

Latest close8.164
Day change-0.75%
Window high9.415
Window low7.938
96-bar change-12.53%
SnapshotDaily · 96 bars
As of2026-07-23 13:30 UTC

Weekly outlook: the last 104 weekly closes (-18.34% over the window).

11.18287.813205 Aug24 Jul

Source rail: Yahoo Finance chart API (LGHT). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for LGHT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

LGHT public profile

Company

Exchange-traded fund. Langar Global HealthTech ETF is connected to current market context, cited company sources and its retained research file.

Market

Langar Global HealthTech ETF trades as LGHT on BATS. Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. LGHT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

The LGHT ETF pitches itself as a cutting-edge thematic play in the $3.5 trillion global healthcare sector, but a glance at its top holdings reveals a less glamorous reality: the fund's largest position is UnitedHealth Group, a company that's been around since 1977 and derives most of its revenue from good old-fashioned insurance premiums. This is like buying a 'Future of Transportation' ETF only to discover it's mostly filled with Ford and GM. The fund's prospectus promises exposure to 'disruptive innovation,' yet its top three holdings are all companies that have been around longer than the internet. It's the thematic investing equivalent of a self-driving car that still needs a steering wheel (source: SEC EDGAR...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Langar Global HealthTech ETF today

Open full report
LGHT daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

The LGHT ETF (Langar Global HealthTech ETF) listed on Nasdaq continues to trade with a mandate focused on health technology firms, though its actual holdings reveal a more conservative posture than its marketing suggests. As of its latest SEC filings, the fund holds a basket skewed toward established medical device companies rather than high-growth digital health startups, raising questions about the alignment of its thematic pitch with portfolio reality.

At its core, LGHT charges a 0.55% expense ratio to track a global index of healthtech companies, but FINRA’s Fund Analyzer highlights that its liquidity profile remains 'moderate,' a euphemism for trading volumes that won’t win any races. The fund’s top holdings include firms with decades-long histories, which may comfort some investors but does little to justify the 'innovation' buzzword in its prospectus.

While the SEC’s EDGAR database confirms LGHT’s regulatory compliance and fee structure, it offers no insight into recent performance metrics or asset growth, which remain undisclosed in this analysis. The fund’s tracking method-designed to mirror a proprietary healthtech index-has not been independently verified for deviation in this report, leaving traders to rely on issuer disclosures that read like a brochure for a clinic that mostly does flu shots.

Market activity on Nasdaq shows LGHT trading in a narrow range, though without disclosed volume figures, it’s impossible to gauge institutional interest. The absence of concrete data on assets under management or recent inflows forces analysts to treat the fund as a black box, where the only certain number is the fee you pay to peer inside.

In the absence of parsed financial figures, LGHT’s story hinges on the tension between its aspirational branding and the unglamorous reality of its holdings. A deeper dive into its index methodology or a surge in trading volume could reshape this narrative, but for now, it remains a case study in how ETFs package the future in yesterday’s wrapper.

Sources & evidence · 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
LGHT
Exchange
BATS
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

LGHT technical readout

Trend strength (ADX 14)
17.8
Average true range (ATR 14)
0.1245
ATR as % of price
1.52%
Volatility compression (ATR14/ATR50)
1.10x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-23. Indicators are descriptive statistics, not investment advice.

Source authority

LGHT evidence rails

Atlas uses the specific public rails available for LGHT: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on LGHT

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for LGHT Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep LGHT research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

LGHT FAQ

What is Langar Global HealthTech ETF (LGHT)?Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. Use this page to check the price chart, company context,...

Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for LGHT?Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. It brings the latest available chart, company context, cited...

Langar Global HealthTech ETF (LGHT) has a latest verified close of 8.164, down 0.75%, dated 23 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. LGHT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the LGHT page updated?The LGHT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The LGHT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for LGHT?The LGHT file starts with Nasdaq Trader and TradingView BATS:LGHT. The page separates verified market context from company evidence and shows open evidence gaps instead...

The LGHT file starts with Nasdaq Trader and TradingView BATS:LGHT. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on LGHT?Yes. The workstation can open LGHT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open LGHT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this LGHT page investment advice?No. The LGHT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The LGHT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →